The study will evaluate two-compartment dosimetry (normal tissue and tumour absorbed dose) in hepatocellular carcinoma patients in interventional oncology in an effort towards a more personalised approach to Y-90 radioembolization for liver cancer patients.
The UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing (MIB) stating that National Health Service (NHS) doctors and commissioners may consider SIR-Spheres Yttrium-90 (Y-90) resin microspheres as an alternative to standard therapy with transarterial chemoembolization (TACE) or sorafenib in the treatment of patients with inoperable primary liver cancer (hepatocellular carcinoma or HCC).
BTG has announced the launch of LC Bead Lumi in the USA, the first commercially available radiopaque embolic bead for the embolization of hypervascular tumours and arteriovenous malformations. LC Bead Lumi is a next generation development of LC Bead.
A study has found that radiofrequency ablation to treat liver metastases in patients with colorectal cancer, induces antitumour immune responses in human samples of primary colon tumour.
Penumbra has announced the launch of the Lantern microcatheter at the upcoming Society of Interventional Radiology annual scientific meeting (SIR 2016, 2-7 April, Vancouver, Canada).
Merit Medical has announced receiving notification of substantial equivalence from the US FDA for the Corvocet Biopsy System, which is intended for use in obtaining core biopsy samples from the liver, kidney, prostate, breast, lung and various other soft tissue tumours.
Merit Medical Systems has announced its schedule of activity for the upcoming Society of Interventional Radiology (SIR) Meeting, being held in Vancouver, Canada, April 2-7 2016.
The US Food and Drug Administration has cleared Corindus Vascular Robotics’ CorPath system for use in peripheral vascular interventions.
Studies have indicated that patterns of restenosis affect long-term outcomes following retreatment in the superficial femoral artery. Gary Ansel, OhioHealth/Riverside Methodist Hospital, Columbus, USA, presented results at the Leipzig Interventional Course (LINC; 26–29 January 2016, Leipzig, Germany) showing that, when in-stent restenosis occurs, it is more often focal with a drug-eluting stent (Zilver PTX, Cook Medical), whereas it is more diffuse with bare metal stents. The drug-eluting device, according to Ansel, yields less restenosis, less reintervention and reduced plaque burden.
Two studies presented at the European Congress of Radiology (2–6 March, Vienna, Austria) have found that radiofrequency ablation could have a role in the treatment of thyroid nodules.
Boehringer Ingelheim has announced the enrolment of the first patient in RE-COVERY DVT/PE, a global observational study on the management of deep vein thrombosis (DVT) and pulmonary embolism (PE).
The Mount Sinai Hospital, New York City, USA has become the first in the country to offer radiopaque bead treatment for liver cancer patients. The minimally invasive treatment using the M1 Lumi Bead loaded with doxorubicin, is now available for patients with inoperable and difficult-to-treat liver cancer.
The US Food and Drug Administration has announced a proposal to ban most powdered gloves in the USA. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to them, which cannot be corrected through new or updated labelling, according to an FDA news release.
The Netherlands Healthcare Institute has approved reimbursement of radioembolization for patients with colorectal liver metastases who have failed prior treatment. The institute based its decision on the clinical evidence of the efficacy and safety of SIR-Spheres (Sirtex) Y-90 resin microspheres for treating this patient group, a press release from Sirtex says.
“Charles Dotter’s vision transformed the diagnostic catheter into a therapeutic tool and set the foundation for image-guided intervention, and as interventionalists, we have attempted to make the scalpel obsolete by employing technology to treat patients non-operatively. However, today, there is another revolution occurring—theranostics,” said Alan Matsumoto, during his delivery of the Charles J Tegtmeyer Lecture at the International Symposium on Endovascular Therapy (ISET, Hollywood, USA) 2016.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos